Emma Baglini

560 total citations
28 papers, 394 citations indexed

About

Emma Baglini is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Emma Baglini has authored 28 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Organic Chemistry and 9 papers in Oncology. Recurrent topics in Emma Baglini's work include Metal complexes synthesis and properties (5 papers), Enzyme function and inhibition (4 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Emma Baglini is often cited by papers focused on Metal complexes synthesis and properties (5 papers), Enzyme function and inhibition (4 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Emma Baglini collaborates with scholars based in Italy, United States and Czechia. Emma Baglini's co-authors include Elisabetta Barresi, Sabrina Taliani, Federico Da Settimo, Silvia Salerno, Tiziano Marzo, Claudia Martini, Alessandro Pratesi, Francesco Bartoli, Damiano Cirri and Anna María Marini and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Emma Baglini

25 papers receiving 391 citations

Peers

Countries citing papers authored by Emma Baglini

Since Specialization

Citations

This map shows the geographic impact of Emma Baglini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Baglini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Baglini more than expected).

Fields of papers citing papers by Emma Baglini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Baglini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Baglini. The network helps show where Emma Baglini may publish in the future.

Co-authorship network of co-authors of Emma Baglini

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Baglini. A scholar is included among the top collaborators of Emma Baglini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Baglini. Emma Baglini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	2-(Phenylamino)-7,8-dihydroquinazolin-5(6H)-one, a promising scaffold for MAO-B inhibitors with potential GSK3β targeting 2025 ·European Journal of Medicinal Chemistry ·Maria Luisa Di Paolo, Silvia Salerno, (unknown), (unknown), Stefania Sarno, (unknown), (unknown), (unknown), Antonella Borreca, Emma Baglini, Elisabetta Barresi, Federico Da Settimo, Sandro Cosconati, Sabrina Castellano, Sabrina Taliani, Lisa Dalla Via	1
2	Repurposing Auranofin for Oncology and Beyond: A Brief Overview of Clinical Trials as Mono- and Combination Therapy 2025 ·Pharmaceuticals ·(unknown), (unknown), Monica Viviano, Raffaella Belvedere, Silvia Salerno, Emma Baglini, Federico Da Settimo, Tiziano Marzo, Sabrina Taliani, Elisabetta Barresi	0
3	Pursuing Polypharmacology: Benzothiopyranoindoles as G-Quadruplex Stabilizers and Topoisomerase I Inhibitors for Effective Anticancer Strategies 2024 ·ACS Medicinal Chemistry Letters ·Silvia Salerno, Elisabetta Barresi, (unknown), (unknown), (unknown), (unknown), (unknown), Emma Baglini, Jussara Amato, Erica Salvati, Lisa Dalla Via, Federico Da Settimo, Sandro Cosconati, Sabrina Taliani	0
4	Indole-Based Compounds in the Development of Anti-Neurodegenerative Agents 2024 ·Molecules ·Elisabetta Barresi, Emma Baglini, (unknown), (unknown), (unknown), Silvia Salerno, Sabrina Taliani, Federico Da Settimo	26
5	Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents 2023 ·Molecules ·Silvia Salerno, Elisabetta Barresi, Emma Baglini, (unknown), Federico Da Settimo, Sabrina Taliani	22
6	Targeting the Translocator Protein (18 kDa) in Cardiac Diseases: State of the Art and Future Opportunities 2023 ·Journal of Medicinal Chemistry ·Emma Baglini, (unknown), Chiara Cavallini, (unknown), Francesca Forini, Giuseppina Nicolini, Elisabetta Barresi, Silvia Salerno, Barbara Costa, Patricia Iozzo, Danilo Neglia, Luca Menichetti, Sabrina Taliani, Federico Da Settimo	5
7	A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells 2023 ·European Journal of Medicinal Chemistry ·Elisabetta Barresi, (unknown), (unknown), (unknown), Emma Baglini, (unknown), Marianna Vitiello, Silvia Salerno, Lorena Tedeschi, Federico Da Settimo, Sandro Cosconati, Laura Poliseno, Sabrina Taliani	6
8	Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry 2023 ·Pharmaceuticals ·Elisabetta Barresi, (unknown), Emma Baglini, (unknown), Monica Viviano, Silvia Salerno, Federico Da Settimo, Sabrina Taliani	2
9	The human microglial surveillant phenotype is preserved by de novo neurosteroidogenesis through the control of cholesterol homeostasis: Crucial role of 18 kDa Translocator Protein 2023 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·(unknown), (unknown), Laura Marchetti, Eleonora Da Pozzo, (unknown), Christian H. Wetzel, Emma Baglini, Sabrina Taliani, Federico Da Settimo, Claudia Martini, Barbara Costa	6
10	Carbonic Anhydrase Activators for Neurodegeneration: An Overview 2022 ·Molecules ·(unknown), Silvia Salerno, Emma Baglini, Elisabetta Barresi, Federico Da Settimo, Sabrina Taliani	23
11	Targeting TSPO Reduces Inflammation and Apoptosis in an In Vitro Photoreceptor-Like Model of Retinal Degeneration 2022 ·ACS Chemical Neuroscience ·(unknown), Emma Baglini, Elisabetta Barresi, Silvia Salerno, Chiara Cerri, Claudia Martini, Federico Da Settimo, Sabrina Taliani, Claudia Gargini, Ilaria Piano	16
12	Cancer Immunotherapy: An Overview of Small Molecules as Inhibitors of the Immune Checkpoint PD-1/PD-L1 (2015-2021) 2022 ·Mini-Reviews in Medicinal Chemistry ·Sabrina Taliani, Emma Baglini, Silvia Salerno, Elisabetta Barresi, Tiziano Marzo, Federico Da Settimo	3
13	New antiproliferative agents derived from tricyclic 3,4‐dihydrobenzo[4,5]imidazo[1,2‐a][1,3,5]triazine scaffold: Synthesis and pharmacological effects 2022 ·Archiv der Pharmazie ·(unknown), Silvia Salerno, Elisabetta Barresi, Paola Orlandi, Francesca Vaglini, (unknown), Francesca Simorini, Emma Baglini, (unknown), Sabrina Taliani, Federico Da Settimo, Guido Bocci	3
14	Dual Targeting Topoisomerase/G-Quadruplex Agents in Cancer Therapy—An Overview 2022 ·Biomedicines ·Silvia Salerno, Elisabetta Barresi, Emma Baglini, (unknown), Sabrina Taliani, Federico Da Settimo	6
15	Inhibition studies on carbonic anhydrase isoforms I, II, IV and IX with N-arylsubstituted secondary sulfonamides featuring a bicyclic tetrahydroindazole scaffold 2021 ·European Journal of Medicinal Chemistry ·Silvia Salerno, Giorgio Amendola, Andrea Angeli, Emma Baglini, Elisabetta Barresi, Anna María Marini, (unknown), Monica Viviano, Sabrina Castellano, Ettore Novellino, Federico Da Settimo, Claudiu T. Supuran, Sandro Cosconati, Sabrina Taliani	13
16	Tetrahydroquinazole-based secondary sulphonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IV, and IX, and computational studies 2021 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Emma Baglini, (unknown), Emanuela Berrino, Silvia Salerno, Elisabetta Barresi, Anna María Marini, Monica Viviano, Sabrina Castellano, Federico Da Settimo, Claudiu T. Supuran, Sandro Cosconati, Sabrina Taliani	6
17	Carbonic anhydrase activation profile of indole-based derivatives 2021 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Elisabetta Barresi, (unknown), (unknown), Andrea Angeli, Emma Baglini, Silvia Salerno, Anna María Marini, Barbara Costa, Eleonora Da Pozzo, Claudia Martini, Federico Da Settimo, Claudiu T. Supuran, Sandro Cosconati, Sabrina Taliani	3
18	Multiple Topoisomerase I (TopoI), Topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs 2020 ·European Journal of Pharmaceutical Sciences ·Emma Baglini, Silvia Salerno, Elisabetta Barresi, (unknown), Federico Da Settimo, Sabrina Taliani, Anna María Marini	41
19	Novel positive allosteric modulators of A_2B adenosine receptor acting as bone mineralisation promoters 2020 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Elisabetta Barresi, Chiara Giacomelli, Laura Marchetti, Emma Baglini, Silvia Salerno, Giovanni Greco, Federico Da Settimo, Claudia Martini, Maria Letizia Trincavelli, Sabrina Taliani	11
20	A mixed-valence diruthenium(ii,iii) complex endowed with high stability: from experimental evidence to theoretical interpretation 2020 ·Dalton Transactions ·Elisabetta Barresi, Iogann Tolbatov, Alessandro Pratesi, Valentina Notarstefano, Emma Baglini, Simona Daniele, Sabrina Taliani, Nazzareno Re, Elisabetta Giorgini, Claudia Martini, Federico Da Settimo, Tiziano Marzo, Diego La Mendola	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact